via Bar-Ilan University
New study finds aspirin use for cardiovascular disease may reduce likelihood of infection
Aspirin is an established, safe, and low-cost medication in long-standing common use in prevention and treatment of cardiovascular diseases, and in the past a pain relief and fever reducing medication. The use of aspirin was very popular during the 1918 Spanish Influenza pandemic, several decades before in-vitro confirmation of its activity against RNA viruses. Studies showed that aspirin, in addition to its well-known anti-inflammatory effects, could modulate the innate and adaptive immune responses helping the human immune system battle some viral infections.
With this information in mind Israeli researchers hypothesized that pre-infection treatment with low-dose aspirin (75mg) use might have a potential beneficial effect on COVID-19 susceptibility and disease duration. A joint team from Leumit Health Services, Bar-Ilan University, and Barzilai Medical Center conducted an observational epidemiological study, utilizing data from Leumit Health Services, a national health maintenance organization in Israel. Their findings were recently published in The FEBS Journal.
The researchers analyzed data of 10,477 persons who had been tested for COVID-19 during the first COVID-19 wave in Israel from February 1, 2020 to June 30, 2020. Aspirin use to avoid the development of cardiovascular diseases in healthy individuals was associated with a 29% lower likelihood of COVID-19 infection, as compared to aspirin non-users. The proportion of patients treated with aspirin was significantly lower among the COVID-19-positive individuals, as compared to the COVID-19-negative ones. And those subjects who had been treated with aspirin were less associated with the likelihood of COVID-19 infection than those who were not. Moreover, the group observed that the conversion time of SARS-CoV-2 PCR test results from positive to negative among aspirin-using COVID-positive patients was significantly shorter, and the disease duration was two-three days shorter, depending upon the patients’ pre-existing conditions.
“This observation of the possible beneficial effect of low doses of aspirin on COVID-19 infection is preliminary but seems very promising,” says Prof. Eli Magen from the Barzilai Medical Center, who led the study.
Original Article: Aspirin and COVID-19
More from: Bar-Ilan University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Aspirin and Covid-19
- COVID-19 Pandemic
Latest edition of 'nation's report card' shows American students' mastery of US history and civics declined during the pandemic Fang Bin publicized videos of overcrowded hospitals and bodies in ...
- No measurable progress made in the last decade to reduce premature births, UN report reveals
No measurable progress has been made in any region of the world in the last decade to reduce the number of babies born prematurely and thus vulnerable to loss of life, a major UN report reveals.
- Symptoms linger 2 years after COVID-19 for 1 in 6 unvaccinated people
People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new research shows.
- Severe COVID-19 raises alarm for undiagnosed cancer
Severe SARS-CoV-2 infection is associated with a 1.31 higher risk of being diagnosed with cancer following hospital discharge, particularly renal, hematological, colon, and lung cancers, suggesting a ...
- Best Covid-19 Travel Insurance Plans Of June 2023
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Covid is still throwing uncertainty into many people’s ...
Go deeper with Google Headlines on:
Aspirin and Covid-19
[google_news title=”” keyword=”aspirin and Covid-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Effect of low doses of aspirin on COVID-19 infection
- Healthy sleep schedule prior to COVID-19 infection prevents long covid: JAMA.
An Original Investigation on Infectious Diseases published in JAMA Network has concluded that establishing a healthy sleep routine before contracting COVID-19 may serve as a preventive ...
- 25% of COVID-19 patients still have symptoms after 18 months
One in four people in Japan who contracted COVID-19 still suffered from side effects 18 months after their infection was confirmed, researchers found. A study of 1,148 individuals aged 20 to 70 ...
- Severe COVID-19 raises alarm for undiagnosed cancer
Severe SARS-CoV-2 infection is associated with a 1.31 higher risk of being diagnosed with cancer following hospital discharge, particularly renal, hematological, colon, and lung cancers, suggesting a ...
- Working night shifts or binge drinking may be risk factors for COVID-19 infection among nurses
Researchers investigated whether unhealthy alcohol use and shift work with subsequent circadian rhythm disruption could increase COVID-19 susceptibility among nurses.
- Current COVID-19 infections in China feature low prevalence level, mild symptoms: experts
The overall COVID-19 infections in China have entered a low prevalence level since mid-May, and the vast majority of COVID-19 patients show mild symptoms, medical experts said. Despite a recent ...
Go deeper with Google Headlines on:
Effect of low doses of aspirin on COVID-19 infection
[google_news title=”” keyword=”effect of low doses of aspirin on COVID-19 infection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
